IV elamipretide: Phase II data

By WIR Staff | Jun 27, 2016 | 7:00 AM GMT

Top-line data from the double-blind, dose-escalation, U.S. Phase II MMPOWER trial in 36 patients with

Read the full 155 word article

How to gain access

Continue reading with a
two-week free trial.